COVID-19

Antirheumatic agents in covid-19: is IL-6 the right target?

Pier Leopoldo Capecchi, Pietro Enea Lazzerini, Luca Volterrani, Maria Antonietta Mazzei, Barbara Rossetti, Giacomo Zanelli, David Bennett, Elena Bargagli, Federico Franchi, Matteo Cameli, Serafina Valente, Luca Cantarini, Bruno Frediani

10.1136/annrheumdis-2020-217523

April 16, 2020